Tuesday, November 17, 2026

Top 5 This Week

Related Posts

Daewoong Luncurkan Fexuprazan di Indonesia, Bawa Terapi P-CAB Generasi Baru untuk GERD

PT Daewoong Pharmaceutical Indonesia has officially launched fexuprazan in Indonesia, introducing a new generation of Potassium-Competitive Acid Blocker (P-CAB) therapy for patients suffering from gastroesophageal reflux disease (GERD).

The product launch took place on Friday, September 18, 2026, during the Indonesian Digestive Disease Week (IDDW) held at the Shangri-La Hotel in Jakarta. The event included a scientific symposium focused on the latest developments in P-CAB therapy and the presentation of clinical evidence regarding the treatment.

Article source: indoposco.id | Image credit: indoposco.id

Follow us on Instagram: @news.tringlobe
Follow WhatsApp channel: Tringlobe Media WhatsApp Channel
Join a WhatsApp group: Join Indonesia WhatsApp group

Follow our Whatsapp channel
Like and follow us on Facebook
News Desk
News Desk
News Desk is the editorial publishing account for Tringlobe Media News, covering breaking news, public affairs, entertainment, community developments and regional stories across Trinidad and Tobago, the Caribbean and internationally.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles

Click to listen highlighted text!